Quality of Life in Patients with Advanced NSCLC Treated in Second-or Third-Line with Nab-Paclitaxel plus Durvalumab: ABOUND. 2L+

Simple item page
dc.contributor.authorTalbot, D.
dc.contributor.authorGovindan, R.
dc.contributor.authorCobo, M.
dc.contributor.authorPonce Aix, S.
dc.contributor.authorPostmus, P. E.
dc.contributor.authorLewanski, C.
dc.contributor.authorBennouna, J.
dc.contributor.authorFischer, J.
dc.contributor.authorJuan-Vidal, O.
dc.contributor.authorStewart, D.
dc.contributor.authorArdizzoni, A.
dc.contributor.authorBhore, R.
dc.contributor.authorWolfsteiner, M.
dc.contributor.authorReck, M.
dc.contributor.authorMorgensztern, D.
dc.contributor.authorOng, T. J.
dc.contributor.authoraffiliation[Talbot, D.] Oxford Univ Hosp NHS Fdn Trust, Oxford, Oxon, England
dc.contributor.authoraffiliation[Govindan, R.] Washington Univ, Sch Med, St Louis, AL USA
dc.contributor.authoraffiliation[Cobo, M.] Hosp Univ Malaga Reg, Ibima, Malaga, Spain
dc.contributor.authoraffiliation[Ponce Aix, S.] H12O Cnio, Unidad Invest Clin Canc Pulmon, Madrid, Spain
dc.contributor.authoraffiliation[Postmus, P. E.] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
dc.contributor.authoraffiliation[Lewanski, C.] Charing Cross Hosp, London, England
dc.contributor.authoraffiliation[Bennouna, J.] Ctr Rene Gauducheau Ctr Lutte Canc Nantes Atlanti, Nantes, Loire Atlantiqu, France
dc.contributor.authoraffiliation[Fischer, J.] Lungenklin Lowenstein GGmbH, Lowenstein, Baden Wurttembe, Germany
dc.contributor.authoraffiliation[Juan-Vidal, O.] Hosp Univ & Politecn La Fe, Valencia, Spain
dc.contributor.authoraffiliation[Stewart, D.] Ottawa Hosp, Ottawa, ON, Canada
dc.contributor.authoraffiliation[Ardizzoni, A.] Azienda Osped Univ Bologna Policlin S Orsola Malp, Bologna, Italy
dc.contributor.authoraffiliation[Bhore, R.] Celgene Corp, Summit, NJ USA
dc.contributor.authoraffiliation[Ong, T. J.] Celgene Corp, Summit, NJ USA
dc.contributor.authoraffiliation[Wolfsteiner, M.] Pra Hlth Sci, Lenexa, KS USA
dc.contributor.authoraffiliation[Reck, M.] German Ctr Lung Res, Airway Res Ctr North, Lungenclin, Grosshansdorf, Germany
dc.contributor.authoraffiliation[Morgensztern, D.] Washington Univ, Sch Med, St Louis, MO USA
dc.date.accessioned2025-01-07T16:39:51Z
dc.date.available2025-01-07T16:39:51Z
dc.date.issued2018-10-01
dc.identifier.doi10.1016/j.jtho.2018.08.649
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086418316071/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27925
dc.identifier.wosID454014501283
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.numberS498-S499
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectquality of life
dc.subjectdurvalumab
dc.subjectnab-paclitaxel
dc.titleQuality of Life in Patients with Advanced NSCLC Treated in Second-or Third-Line with Nab-Paclitaxel plus Durvalumab: ABOUND. 2L+
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeMeeting Abstract

Files

Collections

Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía